Molecular Mechanisms of Neurodegeneration
| What |
|
|---|---|
| When |
Dec 03, 2007 12:00 AM
to Dec 07, 2007 12:00 AM |
| Where | Antigua |
| Add event to calendar |
|
Abstracts
Abstracts for both oral and poster presentation which fit within the themes of the conference are now invited.
Oral abstract deadline Extended to Friday21 September
Poster abstract deadlineFriday 19 October
Topics:
- Genetics of neurodegenerative disease
- APP processing and Abeta
- Mechanisms of neurodegenerative disease
- Therapies and diagnostics
Unlimited poster spaces – posters will be on display throughout the conference with two dedicated poster sessions.
Provisional program
| |
Monday 3 December |
|
12:00 - 18:00 |
Registration |
|
18:00 - 18:15 |
Welcome & Introductions |
|
Rudi Tanzi & Abcam |
|
|
18:15 - 19:00 |
Plenary Speaker |
|
Evening reception and buffet |
|
|
Tuesday 4 December |
|
|
07.30 - 09.00 |
Breakfast |
|
Session 1: Genetics of Neurodegenerative Disease |
|
|
09.00 - 09.30 |
Rudi Tanzi |
|
TBC |
|
|
09.30 - 09.45 |
Carmela Abraham |
|
The Anti-Aging Protein Klotho in Aging and Alzheimer’s Disease |
|
|
09:45 - 10:00 |
Christoph Münch |
|
The p150 subunit of dynactin (DCTN1) gene in amyotrophic lateral sclerosis |
|
|
10:00 - 10:30 |
Lars Bertram |
|
TBC |
|
|
Morning Coffee |
|
|
Session 2: APP and Abeta |
|
|
11:00 - 11:30 |
Christian Haass |
|
Molecular Mechanisms of Amyloid ß-Peptide generation |
|
|
11:30 - 12:00 |
Sam Sisodia |
|
Presenilin Function and Dysfunction in Alzheimer’s Disease |
|
|
12:00 - 12:30 |
Tae-Wan Kim |
|
TBC |
|
|
Lunch |
|
|
Free time for social events |
|
|
Session 2: APP and Abeta |
|
|
17:45 - 18:15 |
David Holtzman |
|
Over-expression of ABCA1 in the PDAPP mouse model of Alzheimer’s disease markedly reduces amyloid deposition |
|
|
18:15 - 18:45 |
Charlie Glabe |
|
TBC |
|
|
18:45 - 19:00 |
Doris Kretzschmar |
|
Neurotoxic effects induced by A? peptides derived from the Drosophila Amyloid Precursor Protein (APP) suggest a conserved toxic function of APP proteins |
|
|
19:00 - 19:30 |
Sam Gandy |
|
TBC |
|
|
Poster session and buffet |
|
|
Wednesday 5 December |
|
|
Breakfast |
|
|
Session 3: Mechanisms of Neurodegenerative Diseases |
|
|
09:00 - 09:30 |
Marcy MacDonald |
|
Huntington’s Disease: discerning a novel disease initiating mechanism |
|
|
09.30 - 09.45 |
Bill Van Nostrand |
|
Cerebral microvascular amyloid promotes localized neuroinflammation, neurodegeneration, and behavioral deficits in a transgenic mouse model |
|
|
09:45 - 10:00 |
Karl Herrup |
|
The role of Cdk5 in neuronal cell cycle control and neurodegeneration |
|
|
10:00 - 10:30 |
Andy Dillon |
|
TBC |
|
|
Morning Coffee |
|
|
11:00 - 11:30 |
Don Cleveland |
|
TBC |
|
|
11:30 - 12:00 |
Karen Duff |
|
TBC |
|
|
12:00 - 12:15 |
Doris Albrecht |
|
Neutral endopeptidase-deficient mice show enhanced long-term potentiation in aged hippocampus and amygdala |
|
|
12:15 - 12:30 |
Juliet Knowles |
|
Novel, small molecule p75ntr ligands prevent |
|
|
Lunch |
|
|
Free time for social events |
|
|
Session 4: Diagnostics and Therapies |
|
|
16:00 - 16:30 |
Dora Kovacs |
|
Two different acat inhibitors reduce amyloid pathology in vivo |
|
|
16:30 - 17:00 |
Steve Wagner |
|
TBC |
|
|
17:00 - 17:30 |
Colin Masters |
|
Alzheimer’s disease: Aβ-amyloid as the principal molecular and therapeutic diagnostic target |
|
|
17.30 - 19.30 |
Poster session and drinks |
|
19:30 |
Beach barbeque |
|
Thursday 6 December |
|
|
09:00 - 09:30 |
Roger Nitsch |
|
Immunotherapy of alzheimer’s disease |
|
|
09:30 - 09:45 |
Barbara Scheiber-Mojdehkar |
|
Recombinant human erythropoietin for the treatment of the neurodegenerative disease Friedreich`s ataxia |
|
|
09:45 - 10:00 |
David Cribbs |
|
AD-Immunotherapy: DNA Vaccines, Adjuvants and Animal Models |
|
|
10:00 - 10:30 |
Cindy Lemere |
|
Active Amyloid-Beta (Aß) Immunization Stabilizes or Improves Cognition in Aged Caribbean Vervets |
|
|
Session 6: Abeta Aggregation and Clearance |
|
|
11:30 - 12:00 |
David Holtzman |
|
11:30 - 12:00 |
Charlie Glabe |
|
Lunch and departures |
|

